Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature.
about
Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition.Emerging therapies for adult soft tissue sarcoma.Inhibition of polo like kinase 1 in sarcomas induces apoptosis that is dependent on Mcl-1 suppressionBioengineered human tumor within a bone niche.Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
P2860
Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insulin-like growth factor 1 r ...... the clinical trial literature.
@en
type
label
Insulin-like growth factor 1 r ...... the clinical trial literature.
@en
prefLabel
Insulin-like growth factor 1 r ...... the clinical trial literature.
@en
P2093
P2860
P356
P1433
P1476
Insulin-like growth factor 1 r ...... the clinical trial literature.
@en
P2093
Alison O'Neill
Aykut Uren
David Loeb
Jeffrey Toretsky
Naamah Zitomersky
Neerav Shukla
Nilay Shah
P2860
P304
P356
10.1155/2013/450478
P50
P577
2013-01-28T00:00:00Z